In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors

The high mortality rate from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in humans and the lack of effective therapeutic regime for its treatment necessitates the identification of new antivirals. SARS-CoV-2 relies on non-structural proteins such as Nsp13 helicase and...

Descripción completa

Detalles Bibliográficos
Autor principal: Gurung, Arun Bahadur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452913/
https://www.ncbi.nlm.nih.gov/pubmed/32875166
http://dx.doi.org/10.1016/j.genrep.2020.100860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452913/
https://www.ncbi.nlm.nih.gov/pubmed/32875166
http://dx.doi.org/10.1016/j.genrep.2020.100860

Ejemplares similares